Surgeons across the country are implementing DEXTENZA to optimize patient care in their practices.

Map and locations not to scale.


View interviews with surgeons that explain several benefits of using DEXTENZA.

Shamik Bafna, MD
Cleveland Eye Clinic
Cleveland, OH

Sumitra Khandelwal, MD
Baylor College of Medicine
Houston, TX

Dee Stephenson, MD
Stephenson Eye Associates
Venice, FL

Zaina Al-Mohtaseb, MD
Alkek Eye Center
Houston, TX

Tal Raviv, MD
Eye Center of New York
New York, NY

Paul Singh, MD
The Eye Centers of Racine & Kenosha
Racine, WI & Kenosha, WI

Mitchell A. Jackson, MD
Lake Villa, IL

Now it’s your turn

Contact your local Key Account Manager or Click Here for your opportunity to use DEXTENZA with your patients.

Become a Big Time Innovator

Full Prescribing Information

DEXTENZA is contraindicated in patients with active corneal, conjunctival or canalicular infections, including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, varicella; mycobacterial infections; fungal diseases of the eye, and dacryocystitis.

Warnings and Precautions
Prolonged use of corticosteroids may result in glaucoma with damage to the optic nerve, defects in visual acuity and fields of vision. Steroids should be used with caution in the presence of glaucoma. Intraocular pressure should be monitored during treatment.

Corticosteroids may suppress the host response and thus increase the hazard for secondary ocular infections. In acute purulent conditions, steroids may mask infection and enhance existing infection.

Use of ocular steroids may prolong the course and may exacerbate the severity of many viral infections of the eye (including herpes simplex).

Fungus invasion must be considered in any persistent corneal ulceration where a steroid has been used or is in use. Fungal culture should be taken when appropriate.

Use of steroids after cataract surgery may delay healing and increase the incidence of bleb formation.

Adverse Reactions
The most common ocular adverse reactions that occurred in patients treated with DEXTENZA were: anterior chamber inflammation including iritis and iridocyclitis (10%); intraocular pressure increased (6%); visual acuity reduced (2%); cystoid macular edema (1%); corneal edema (1%); eye pain (1%) and conjunctival hyperemia (1%).

The most common non-ocular adverse reaction that occurred in patients treated with DEXTENZA was headache (1%).


DEXTENZA is a corticosteroid indicated for the treatment of ocular inflammation and pain following ophthalmic surgery.